CTI forms customer financing alliance:
This article was originally published in Clinica
CTI Molecular, which provides PET equipment, radiopharmaceuticals and services, is to work with independent healthcare financier DVI to introduce a new customer financing platform. Under the alliance, known as CTI Financial Services, CTI customers can finance all CTI products and services by monthly payments. The alliance between the two companies, based in Knoxville, Tennessee and Jamison, Pennsylvania, also provides a dedicated team to construct appropriate financing arrangements for domestic and international accounts. The equipment market for PET is estimated to reach $3bn in 2006, according to Frost & Sullivan.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.